The efficacy of sorafenib administration prior to TACE against the patients with intermediate HCC refractory to TACE
Latest Information Update: 06 Jan 2014
At a glance
- Drugs Sorafenib (Primary) ; Antineoplastics
- Indications Liver cancer
- Focus Adverse reactions
- 06 Jan 2014 New trial record